Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion type Assertion NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_head.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion description "[Changes in the expression of some genes, confirmed by real-time RT-PCR, (CD36, leucine-rich repeats and immunoglobulin-like domains-1, tissue factor pathway inhibitor 2, myeloid cell nuclear differentiation antigen, tumor necrosis factor receptor superfamily, member 25, CD96 and lipoprotein lipase), may be related to a proinflammatory environment in FCH monocytes, which is partially reversed by atorvastatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_provenance.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion evidence source_evidence_literature NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_provenance.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion SIO_000772 18681780 NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_provenance.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion wasDerivedFrom befree-20140225 NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_provenance.
- NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_assertion wasGeneratedBy ECO_0000203 NP703267.RAQVGwhvYGXlCBbdwO4xMW3gNP5cUTzY9hFXX-JpojpQc130_provenance.